Results 211 to 220 of about 51,615 (305)

Diagnosis of myelodysplastic syndromes: the classic and the novel. [PDF]

Haematologica
Oster HS, Van de Loosdrecht AA, Mittelman M.   +2 more
europepmc   +1 more source

Flow Cytometry: Advances, Challenges and Trends

BioEssays, Volume 48, Issue 1, January 2026.
Recent advances in flow cytometry span hardware, data processing, and AI‐driven analytics. Emerging modalitiesincluding spectral, imaging, mass, and nano/EV cytometryenable higher‐parameter and small‐particle detection. Integrated machine learning drives a shift from manual gating toward automated multi‐omics workflows.
J. Paul Robinson, Grzegorz B. Gmyrek, Bartek Rajwa   +2 more
wiley   +1 more source

Research progress on ferroptosis in Myelodysplastic syndromes. [PDF]

Front Pharmacol
Yang Y, Han J, Wei Y, Jin J, Feng W.
europepmc   +1 more source

A nationwide non-interventional epidemiological data registry on myelodysplastic syndromes in Lebanon [PDF]

, 2015
et al.,, Otrock, Zaher K
core   +1 more source

Hemi‐Orolingual Angioedema in a Patient With VEXAS Syndrome

eJHaem, Volume 7, Issue 1, February 2026.
Edwin U. Suárez, Teresa Arquero‐Portero, Pilar Llamas‐Sillero   +2 more
wiley   +1 more source

Immune‐Mediated Thrombocytopenia in an Ulcerative Colitis Patient After Initiating Filgotinib Treatment: A Case Report

Clinical Case Reports, Volume 14, Issue 1, January 2026.
Timeline of events ABSTRACT Moderate‐to‐severe ulcerative colitis can be effectively treated with JAK‐1 inhibition, but platelet counts should be closely monitored, especially in active disease. We confirmed immune‐mediated thrombocytopenia (ITP) in one of our patients after the initiation of filgotinib. Whether this was drug‐induced is uncertain.
M. J. van der Hoff, F. El‐Morabit, M. Löwenberg   +2 more
wiley   +1 more source

Omacetaxine and azacitidine for untreated patients with myelodysplastic syndromes and excess blasts: a phase I/II clinical trial. [PDF]

EClinicalMedicine
Pollyea DA, Stevens BM, Abbott D, Amaya M, Gutman JA, Kent A, McMahon C, Schwartz M, Smith C, Dell-Martin J, Sohalski C, Ellis A, Haag M, Schowinsky J, Pan Z, Patel SB, Ransom M, Gillen A, Jordan CT, Pietras EM.   +19 more
europepmc   +1 more source

Phagocytosis of Lymphocytes and Erythrocytes by B‐Cell Lymphoma in a Patient With a Clinical Suspicion of Pure Red Cell Aplasia

Clinical Case Reports, Volume 14, Issue 1, January 2026.
ABSTRACT Herein, we report a diagnostically challenging case of a B‐cell lymphoma initially masquerading as pure red cell aplasia (PRCA). The key to diagnosis was the unique finding of phagocytic activity (engulfing erythrocytes and lymphocytes) by atypical mature lymphocytes in both peripheral blood and bone marrow, accompanied by clinical signs of ...
Tuo Cao, Yuting Li, Xiangming Peng
wiley   +1 more source

Deciphering clinical features and treatment patterns of thrombocytopenic myelodysplastic syndromes. [PDF]

Ann Hematol
Galli N, Pettine L, Croci G, Passamonti F, Barcellini W, Fattizzo B.   +5 more
europepmc   +1 more source

A Diagnostic Challenge: Post‐Transfusion Purpura Unmasked After Multiple Transfusions

Clinical Case Reports, Volume 14, Issue 1, January 2026.
ABSTRACT Post‐transfusion purpura (PTP) is a rare immune‐mediated post‐transfusion reaction resulting in severe thrombocytopenia. This case presents a 52‐year‐old female with profound thrombocytopenia following multiple transfusions. PTP was not initially suspected due to her history of comorbid anti‐phospholipid antibody syndrome (APS), chemotherapy ...
Jacintha Thomas, Priyal Gopalan, Tanya M. Wildes   +2 more
wiley   +1 more source